Viking Therapeutics Inc (VKTX)
76.43
-3.15
(-3.96%)
USD |
NASDAQ |
May 01, 16:00
77.20
+0.77
(+1.01%)
After-Hours: 07:42
Viking Therapeutics Shares Outstanding: 110.27M for April 15, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 15, 2024 | 110.27M |
March 31, 2024 | 110.23M |
March 28, 2024 | 110.22M |
March 15, 2024 | 110.07M |
March 04, 2024 | 109.36M |
February 27, 2024 | 101.91M |
January 31, 2024 | 100.49M |
December 31, 2023 | 100.11M |
October 15, 2023 | 100.03M |
September 30, 2023 | 100.03M |
July 15, 2023 | 100.03M |
June 30, 2023 | 100.03M |
April 21, 2023 | 99.84M |
April 16, 2023 | 99.58M |
April 15, 2023 | 99.58M |
April 03, 2023 | 98.26M |
March 31, 2023 | 79.32M |
February 27, 2023 | 78.44M |
January 31, 2023 | 78.42M |
December 31, 2022 | 78.26M |
October 15, 2022 | 76.69M |
September 30, 2022 | 76.69M |
July 15, 2022 | 76.69M |
June 30, 2022 | 76.69M |
April 15, 2022 | 77.37M |
Date | Value |
---|---|
March 31, 2022 | 77.37M |
January 31, 2022 | 78.36M |
December 31, 2021 | 78.25M |
October 15, 2021 | 78.23M |
September 30, 2021 | 78.23M |
July 15, 2021 | 78.19M |
June 30, 2021 | 78.19M |
April 15, 2021 | 78.10M |
March 31, 2021 | 77.18M |
January 31, 2021 | 74.13M |
December 31, 2020 | 73.22M |
October 15, 2020 | 72.95M |
September 30, 2020 | 72.92M |
July 15, 2020 | 72.76M |
June 30, 2020 | 72.76M |
April 15, 2020 | 72.60M |
March 31, 2020 | 72.56M |
January 31, 2020 | 72.56M |
December 31, 2019 | 72.41M |
October 31, 2019 | 72.26M |
September 30, 2019 | 72.26M |
July 31, 2019 | 72.21M |
June 30, 2019 | 72.17M |
April 30, 2019 | 72.05M |
April 01, 2019 | 72.03M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
72.17M
Minimum
Jun 30 2019
110.27M
Maximum
Apr 15 2024
84.76M
Average
78.21M
Median
Shares Outstanding Benchmarks
Eli Lilly and Co | 950.41M |
Pfizer Inc | 5.647B |
Madrigal Pharmaceuticals Inc | 19.90M |
Akero Therapeutics Inc | 68.95M |
Terns Pharmaceuticals Inc | 64.65M |